gliomatosis cerebri rare form diffusely infiltrating glioma typically resistant conventional chemotherapy radiation therapy carries poor prognosis temozolomide shown antineoplastic activity malignant gliomas recently beneficial patient gliomatosis cerebri make objective assessment effect temozolomide administration patient gliomatosis cerebri used brain proton magnetic resonance spectroscopy structural mri man gliomatosis cerebri treated temozolomide NUMBER day NUMBER days NUMBER days cycles temozolomide resulted marked reduction choline content detected using brain proton mr spectroscopy indicating reduced tumor cellularity growth rate neurochemical improvements associated normalization signal intensity previously affected cerebral regions regression mass effect mri left pyramidal syndrome present start treatment disappeared observation lends support larger clinical trials evaluating use temozolomide treat brain tumor long term NUMBER year old scyllo inositol mg m2